In the latest episode of Penn Today’s ‘Office Hours’ podcast series, a casual chat with Kathy DeMarco Van Cleve, senior lecturer in Cinema and Media Studies.
Welcome to the “office hours” of Kathy DeMarco Van Cleve, senior lecturer of Cinema and Media Studies in the School of Arts and Sciences.
Here, in the latest episode of the “Office Hours” podcast produced by Penn Today, which explores the minds of the University’s academic talents in a more unbuttoned and freewheeling setting outside of the lecture hall, Van Cleve joins for a look back on the 2019 Oscars, exploring what The Academy got right and wrong this year, and whether it's worth feeling bad for Bradley Cooper. Plus, gab about what she likes to munch on, reflection on her favorite movie (or movies), and some shout-outs to her favorite places on campus.
When the Schuylkill swallowed the city: Lessons from Hurricane Ida’s historic flood
New Penn research shows that Hurricane Ida wasn’t a once-in-a-century anomaly but a preview of how climate change, urbanization, and aging infrastructure are rewriting flood risk.
The Fed explained: What it does and why it matters
Former Philadelphia Fed President Patrick Harker and financial historian Peter Conti-Brown, both Wharton professors, unpack the central bank’s origins, its unusual structure, and the quiet ways it shapes the economy
How population changes are impacting primary education worldwide
Research from Penn sociologist Emily Hannum and colleagues reveals regional trends in whether school-age populations are increasing, plateauing, or decreasing—and shows how different countries are responding.
A bioengineered bean gum from the lab of Penn Dental’s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth.
Fighting oral cancer with bioengineered chewing gum
Research led by Penn Dental’s Henry Daniell shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.
